van der Sande et al developed a prediction model to predict cardiovascular events within 3 years among patients with prevalent DN treated with angiotensin receptor blockers.18 Age, gender, smoking, SBP, urinary albumin/creatinine ratio, eGFR, albumin and phosphate were included as predictors. This evidence concerns the gene ALB and liver dysplastic nodule.